Intralesional interleukin-2 augmentation therapy in treatment-refractory melanomaDERMATOLOGIC THERAPYIF3.42022-10-061OA
Integrative and perturbation-based analysis of the transcriptional dynamics of TGFβ/BMP system components in transition from embryonic stem cells to neural progenitorsStem CellsIF3.62019-11-2324PREAI
No Causal Link between Phosphodiesterase Type 5 Inhibition and MelanomaWORLD JOURNAL OF MENS HEALTHIF4.12019-01-013OAAI
What is your time worth? Comparison of distance travelled and waiting time between online and in-person care models from a randomized controlled trialJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-010OAAI
Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy玻璃体内抗VEGF治疗新生血管性年龄相关性黄斑变性视力结果良好与不良的基线预测指标INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72015-08-0346OAAI
Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular DegenerationJOURNAL OF CLINICAL MEDICINEIF2.92015-07-0859OAAI
The Incidence of Neovascular Subtypes in Newly Diagnosed Neovascular Age-Related Macular DegenerationAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22014-10-01156PREAI
Risk Factors Associated With Reticular Pseudodrusen Versus Large Soft DrusenAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22014-05-0162OAAI
Association Between Geographic Atrophy Progression and Reticular Pseudodrusen in Eyes With Dry Age-Related Macular DegenerationINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72013-11-08158OAAI